EANS-News: W.O.M. World of Medicine AG / H1/2009: Return on sales within the 2009 target corridor

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

balance/Half-year Report

Berlin (euro adhoc) - The return on sales before taxes of medical
device manufacturer W.O.M. WORLD OF MEDICINE AG equaled 5.6% in the
first half-year of 2009, and thus reached the target corridor for
2009 (6%), which the Management Board revised in May. Sales reflect a
decline in the first six months of 2009 by 13.7% to TEUR17,367. The
first half-year of 2008 was hallmarked by its above- average sales
pace following placement of major orders, specifically in the camera
division.

"The second quarter progressed with anticipated restraint," says CEO
Peter P. Wiest. "However, in view of the strategic direction set for
the next few years, these figures merely represent a snapshot of the
difficult year 2009. We are investing in new sales regions such as
Southeast Asia, the Middle East and South America, in order to
generate a counterbalance to today's weakened US market. And an
important component: Our presentation at the 'Hospitalar' trade show
in June in Brazil. As a result, in the first half-year 2009, sales in
the Rest of World segment rose once again: by 21.6% to TEUR2,113. In
addition, we are stepping up our investments in research and
development."

The transition to the new generation of Medical-HD® cameras, which
have been batch shipped to specialized retailers since June, is
currently underway. In addition, in the 2nd half-year a new
multifunction pump will be brought to the market, and contracts with
OEM customers for new pump systems were executed, which are expected
to come to market within the next 12 months. "We are therefore
focusing on our strategic orientation for the next few years, in
order to expand the Company's market position and secure our employee
positions over the medium- and long-term," says Peter P. Wiest.

According to Wiest, the current year still leaves many issues
unanswered. "We anticipate that - given a cyclical time-delay with
the USA - the crisis will be much more palpable in Europe in the
second half-year of 2009. For this reason, we anticipate a similarly
weak 3rd quarter 2009. There are indications of a recovery in the US
market in the 4th quarter. Nevertheless, a current outlook from July
based on the H1 figures shows uncertainties for reaching the sales
and earnings goals set in May if the shift in trends will be
postponed to the 1st half-year 2010."

The complete 2009 Half-Year Financial Report is available at: www.wor
ld-of-medicine.com/wsc/pdf/wom/en/qr_halfyearreport_2009_wom.pdf

WORLD OF MEDICINE and its technologies are paving the way in
Minimally Invasive Surgery - or MIS for short. This approach includes
safe and gentle surgical procedures conducted not through major
incisions, but through keyhole or puncture incisions. The Company is
the global market leader in a niche of this future market.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: W.O.M. WORLD OF MEDICINE AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Stefanie Gehrke

Cell Phone: + 49 (0) 172 402 67 40

E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / free trade